Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GBM-2 by Cellworks Group for Glioblastoma Multiforme (GBM): Likelihood of Approval
GBM-2 is under clinical development by Cellworks Group and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData,...